DE602005018554D1 - Aminoarylsulfonamidderivate als funktionelle 5-ht6-liganden - Google Patents

Aminoarylsulfonamidderivate als funktionelle 5-ht6-liganden

Info

Publication number
DE602005018554D1
DE602005018554D1 DE602005018554T DE602005018554T DE602005018554D1 DE 602005018554 D1 DE602005018554 D1 DE 602005018554D1 DE 602005018554 T DE602005018554 T DE 602005018554T DE 602005018554 T DE602005018554 T DE 602005018554T DE 602005018554 D1 DE602005018554 D1 DE 602005018554D1
Authority
DE
Germany
Prior art keywords
derivatives
aminoarylsulfonamide
ligands
functional
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005018554T
Other languages
English (en)
Inventor
Venkata Satya Ramakrishna
Vikas Shreekrishna Shirsath
Rama Sastri Kambhampati
Santosh Vishwakarma
Nagaraj Vishwottam Kandikere
Srinivasulu Kota
Venkateswarlu Jasti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suven Life Sciences Ltd
Original Assignee
Suven Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Ltd filed Critical Suven Life Sciences Ltd
Publication of DE602005018554D1 publication Critical patent/DE602005018554D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Insulated Gate Type Field-Effect Transistor (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
DE602005018554T 2005-08-12 2005-10-26 Aminoarylsulfonamidderivate als funktionelle 5-ht6-liganden Active DE602005018554D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1127CH2005 2005-08-12
PCT/IN2005/000345 WO2007020652A1 (en) 2005-08-12 2005-10-26 Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands.

Publications (1)

Publication Number Publication Date
DE602005018554D1 true DE602005018554D1 (de) 2010-02-04

Family

ID=36130030

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005018554T Active DE602005018554D1 (de) 2005-08-12 2005-10-26 Aminoarylsulfonamidderivate als funktionelle 5-ht6-liganden

Country Status (23)

Country Link
US (1) US7998981B2 (de)
EP (1) EP1919896B1 (de)
JP (1) JP5091138B2 (de)
KR (1) KR101016972B1 (de)
CN (1) CN101258144B (de)
AT (1) ATE452885T1 (de)
AU (1) AU2005335620B2 (de)
BR (1) BRPI0520579B8 (de)
CA (1) CA2618636C (de)
CY (1) CY1110276T1 (de)
DE (1) DE602005018554D1 (de)
DK (1) DK1919896T3 (de)
EA (1) EA013875B1 (de)
ES (1) ES2337167T3 (de)
HK (1) HK1116796A1 (de)
MX (1) MX2008002018A (de)
NO (1) NO340511B1 (de)
NZ (1) NZ566495A (de)
PL (1) PL1919896T3 (de)
PT (1) PT1919896E (de)
SI (1) SI1919896T1 (de)
WO (1) WO2007020652A1 (de)
ZA (1) ZA200801276B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8470830B2 (en) 2007-01-08 2013-06-25 Suven Life Sciences Limited 5-(heterocyclyl)alkyl-N-(arylsulfonyl)indole compounds and their use as 5-HT6 ligands
ATE513810T1 (de) * 2007-05-03 2011-07-15 Suven Life Sciences Ltd Aminoalkoxy-aryl-sulfonamidverbindungen und ihre verwendung als 5-ht6-liganden
EA017154B1 (ru) * 2007-10-26 2012-10-30 Сувен Лайф Сайенсиз Лимитед Аминоарилсульфонамидные соединения и их применение в качестве 5-нтлигандов
WO2010032257A1 (en) * 2008-09-17 2010-03-25 Suven Life Sciences Limited Aryl indolyl sulfonamide compounds and their use as 5-ht6 ligands
DK2521714T3 (en) * 2010-01-05 2015-10-19 Suven Life Sciences Ltd Aromatic sulfone compositions useful in the treatment of central nervous disorders
CN102153884B (zh) * 2011-02-16 2013-06-19 连云港清泰化工有限公司 一种墨水型染料及其制备方法与用途
JP6454346B2 (ja) 2013-12-20 2019-01-16 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. 芳香族複素環式化合物及び医薬におけるその応用
JP6515175B2 (ja) 2014-07-08 2019-05-15 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. 芳香族ヘテロ環誘導体及びその医薬的適用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2143992T3 (es) * 1991-11-25 2000-06-01 Pfizer Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas.
DZ2376A1 (fr) 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
EP0994862B1 (de) * 1997-07-11 2005-06-01 SmithKline Beecham plc Sulfonamid-derivate als 5-ht6 receptor antagonisten und verfahren zu ihrer herstellung
GB9801392D0 (en) 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
GB9803411D0 (en) 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds
GB9926302D0 (en) 1999-11-05 2000-01-12 Smithkline Beecham Plc Novel compounds
CN1492863A (zh) * 2000-12-22 2004-04-28 作为5-羟色胺-6配基的杂环基烷基-吲哚或氮杂吲哚化合物
BR0207302A (pt) 2001-02-08 2004-02-10 Memory Pharm Corp Trifluorometilpurinas como inibidores da fosfodiesterase 4
MXPA04001089A (es) * 2001-08-03 2004-05-20 Upjohn Co 5-arilsulfonil indoles que tienen afinidad por el receptor de 5-ht.
EP1472544A2 (de) 2002-02-01 2004-11-03 Bayer HealthCare AG Diagnostika und therapeutika gegen mit einem neuen menschlichen 5-ht6-rezeptor assoziierten krankheiten
WO2003066056A1 (en) 2002-02-05 2003-08-14 Glaxo Group Limited Method of promoting neuronal growth
MXPA04008097A (es) 2002-02-22 2004-11-26 Upjohn Co Derivados de piridilsulfona como antagonistas del receptor 5-ht.
CN1293053C (zh) * 2002-06-05 2007-01-03 弗·哈夫曼-拉罗切有限公司 作为5-ht6-受体调节剂用于治疗cns-病症的1-磺酰基-4-氨基烷氧基吲哚衍生物
KR20050073560A (ko) * 2002-10-18 2005-07-14 에프. 호프만-라 로슈 아게 5-ht6 수용체 친화성을 갖는 4-피페라진일 벤젠설폰일인돌
AU2003285759B2 (en) 2002-11-28 2010-01-28 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindoles
WO2004048331A1 (en) 2002-11-28 2004-06-10 Suven Life Sciences Limited N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands
KR100818508B1 (ko) 2002-11-28 2008-03-31 수벤 라이프 사이언시스 리미티드 세로토닌 수용체 친화력을 가지는 엔-아릴술포닐-3-치환인돌, 그 제조방법 및 그를 포함하는 약제학적 조성물
PT1581538E (pt) 2002-12-18 2007-05-31 Suven Life Sciences Ltd Indolos tetracíclicos substituidos na posição 3 que possuem afinidade pelo receptor de serotonina.
ES2385219T3 (es) * 2003-09-12 2012-07-19 Merck Serono Sa Derivados de sulfonamida para el tratamiento de diabetes

Also Published As

Publication number Publication date
US7998981B2 (en) 2011-08-16
CA2618636A1 (en) 2007-02-22
NO20080705L (no) 2008-05-06
AU2005335620A1 (en) 2007-02-22
ATE452885T1 (de) 2010-01-15
PL1919896T3 (pl) 2010-05-31
HK1116796A1 (en) 2009-01-02
US20100168168A1 (en) 2010-07-01
CA2618636C (en) 2011-01-18
BRPI0520579B8 (pt) 2021-05-25
BRPI0520579B1 (pt) 2019-08-06
EA013875B1 (ru) 2010-08-30
SI1919896T1 (sl) 2010-04-30
BRPI0520579A2 (pt) 2009-11-10
CN101258144A (zh) 2008-09-03
EP1919896A1 (de) 2008-05-14
DK1919896T3 (da) 2010-04-19
NO340511B1 (no) 2017-05-02
ZA200801276B (en) 2009-02-25
PT1919896E (pt) 2010-02-26
WO2007020652A1 (en) 2007-02-22
EA200800573A1 (ru) 2008-08-29
EP1919896B1 (de) 2009-12-23
CN101258144B (zh) 2012-05-30
JP2009504633A (ja) 2009-02-05
KR20080039984A (ko) 2008-05-07
MX2008002018A (es) 2008-03-27
AU2005335620B2 (en) 2009-12-10
NZ566495A (en) 2010-06-25
KR101016972B1 (ko) 2011-02-25
CY1110276T1 (el) 2015-01-14
ES2337167T3 (es) 2010-04-21
JP5091138B2 (ja) 2012-12-05

Similar Documents

Publication Publication Date Title
NO20080705L (no) Aminoaryl Sulphonamide Derivatives as functional 5-HT6 Ligands
DK1888541T3 (da) Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
ATE427927T1 (de) Phenylacetylenderivate mit affinitat zum mglur5- rezeptor
EA200701853A1 (ru) Производные циклопентапиридина и тетрагидрохинолина
EA200970967A1 (ru) Оксадиазол замещенные производные индазола для применения в качестве агонистов сфингозин 1-фосфата (sip)
MX2009003316A (es) Derivados de pirazina-2-carboxamida como moduladores receptores de cb2.
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
DE602006018713D1 (de) Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate
ATE467632T1 (de) Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors
MX2008002805A (es) Derivados de carboxamida como antagonistas del receptor muscarinico.
ATE467636T1 (de) Pyrazoloä3 , 4-düazepinderivate als histamin-h3- antagonisten
ATE466854T1 (de) 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren
ATE524446T1 (de) Sulfatierte benzimidazolon-derivate mit gemischter serotonin-rezeptor-affinität
ATE505457T1 (de) Isochinoline als igf-1r-inhibitoren
NO20080553L (no) Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander
ATE513810T1 (de) Aminoalkoxy-aryl-sulfonamidverbindungen und ihre verwendung als 5-ht6-liganden
ATE485040T1 (de) Carbazol-derivate als funktionale 5-ht6-liganden
TH95735A (th) อนุพันธ์ 3-ซัลโฟนิลอินดาโซลที่ถูกแทนที่เป็นลิแกนด์ 5-ไฮดรอกซีทริปทามีน-6

Legal Events

Date Code Title Description
8364 No opposition during term of opposition